
Seaport begins phase 2a trial of GlyphAgo for generalized anxiety disorder with sleep disturbance, testing liver-sparing agomelatine dosing and tracking sleep, anxiety outcomes.
How do your fellow clinicians feel about the holidays? Are they feeling the effects of burnout heading into 2025? Find out here.
Earlier this month, we asked the readers of Psychiatric Times a few questions related to the holidays. Here's how you all answered...






